Covered recipient · General Payments record
KARA L CARTHEL
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Psychiatric/Mental Health
General Payments · PY2021
$255.70
- Reported across 19 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2021 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $255.70 | 19 |
By paying entity
PY2021 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $153.33 | 15 |
| Janssen Pharmaceuticals, Inc | $102.37 | 4 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2021 | $255.70 | 19 |
Payment records · PY2021 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $6.33 | 01/26/2021 | Food and Beverage | Undisputed | 01/23/2026 | 796469083 | CMS |
| AbbVie Inc. | $8.08 | 03/10/2021 | Food and Beverage | Undisputed | 01/23/2026 | 796469085 | CMS |
| AbbVie Inc. | $7.53 | 03/29/2021 | Food and Beverage | Undisputed | 01/23/2026 | 796469087 | CMS |
| AbbVie Inc. | $11.57 | 04/07/2021 | Food and Beverage | Undisputed | 01/23/2026 | 796469089 | CMS |
| AbbVie Inc. | $4.45 | 04/29/2021 | Food and Beverage | Undisputed | 01/23/2026 | 796469091 | CMS |
| AbbVie Inc. | $12.50 | 05/11/2021 | Food and Beverage | Undisputed | 01/23/2026 | 796469093 | CMS |
| AbbVie Inc. | $7.13 | 05/19/2021 | Food and Beverage | Undisputed | 01/23/2026 | 796469095 | CMS |
| AbbVie Inc. | $18.70 | 05/19/2021 | Food and Beverage | Undisputed | 01/23/2026 | 796469097 | CMS |
| AbbVie Inc. | $7.73 | 06/07/2021 | Food and Beverage | Undisputed | 01/23/2026 | 796469099 | CMS |
| AbbVie Inc. | $3.28 | 07/12/2021 | Food and Beverage | Undisputed | 01/23/2026 | 796469101 | CMS |
| AbbVie Inc. | $8.25 | 07/19/2021 | Food and Beverage | Undisputed | 01/23/2026 | 796469103 | CMS |
| AbbVie Inc. | $15.75 | 08/17/2021 | Food and Beverage | Undisputed | 01/23/2026 | 796469105 | CMS |
| AbbVie Inc. | $22.02 | 08/26/2021 | Food and Beverage | Undisputed | 01/23/2026 | 796469107 | CMS |
| AbbVie Inc. | $7.63 | 09/16/2021 | Food and Beverage | Undisputed | 01/23/2026 | 796469109 | CMS |
| AbbVie Inc. | $12.38 | 09/30/2021 | Food and Beverage | Undisputed | 01/23/2026 | 796469111 | CMS |
| Janssen Pharmaceuticals, Inc | $27.98 | 02/18/2021 | Food and Beverage | Undisputed | 01/23/2026 | 788250185 | CMS |
| Janssen Pharmaceuticals, Inc | $20.72 | 03/31/2021 | Food and Beverage | Undisputed | 01/23/2026 | 788250183 | CMS |
| Janssen Pharmaceuticals, Inc | $34.80 | 06/16/2021 | Food and Beverage | Undisputed | 01/23/2026 | 788250189 | CMS |
| Janssen Pharmaceuticals, Inc | $18.87 | 08/31/2021 | Food and Beverage | Undisputed | 01/23/2026 | 788250181 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021
- Source files
- Dataset page · Bulk file · PY2021
- Generated from
- OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.